SPDR Series Trust - State Street SPDR S&P Biotech ETF (BMV:XBI)
2,375.00
+14.00 (0.59%)
Last updated: May 29, 2026, 12:33 PM CST
BMV:XBI Holdings Information
BMV:XBI is an equity ETF with a total of 152 individual holdings. The top holdings are Travere Therapeutics stock at 1.82%, Revolution Medicines at 1.76%, Twist Bioscience at 1.67%, Alkermes at 1.63%, and TG Therapeutics at 1.56%.
Total Holdings
152
Top 10 Percentage
15.53%
Asset Class
Equity
ETF Category
Health Care
Assets
144.82B
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | TVTX | Travere Therapeutics, Inc. | 1.82% |
| 2 | RVMD | Revolution Medicines, Inc. | 1.76% |
| 3 | TWST | Twist Bioscience Corporation | 1.67% |
| 4 | ALKS | Alkermes plc | 1.63% |
| 5 | TGTX | TG Therapeutics, Inc. | 1.56% |
| 6 | ARWR | Arrowhead Pharmaceuticals, Inc. | 1.54% |
| 7 | BEAM | Beam Therapeutics Inc. | 1.42% |
| 8 | EXEL | Exelixis, Inc. | 1.39% |
| 9 | KRYS | Krystal Biotech, Inc. | 1.38% |
| 10 | NBIX | Neurocrine Biosciences, Inc. | 1.36% |
| 11 | CYTK | Cytokinetics, Incorporated | 1.36% |
| 12 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.35% |
| 13 | PRAX | Praxis Precision Medicines, Inc. | 1.34% |
| 14 | SRRK | Scholar Rock Holding Corporation | 1.30% |
| 15 | CELC | Celcuity Inc. | 1.28% |
| 16 | CRSP | CRISPR Therapeutics AG | 1.28% |
| 17 | VCYT | Veracyte, Inc. | 1.25% |
| 18 | NUVL | Nuvalent, Inc. | 1.23% |
| 19 | NTRA | Natera, Inc. | 1.23% |
| 20 | MIRM | Mirum Pharmaceuticals, Inc. | 1.23% |
| 21 | PTCT | PTC Therapeutics, Inc. | 1.22% |
| 22 | APGE | Apogee Therapeutics, Inc. | 1.18% |
| 23 | PTGX | Protagonist Therapeutics, Inc. | 1.18% |
| 24 | IONS | Ionis Pharmaceuticals, Inc. | 1.17% |
| 25 | RYTM | Rhythm Pharmaceuticals, Inc. | 1.17% |
As of May 28, 2026